Early infections in childhood drive long-term health risks

Early childhood infections significantly increase the risk of severe infections and antibiotic use later in childhood, highlighting the importance of early prevention and monitoring.

STP-938 by Step Pharma for Mantle Cell Lymphoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

February 8, 2024

Novo Nordisk inks research deal with RNA startup with new delivery approach

Novo Nordisk is collaborating with RNA upstart Eleven Therapeutics in a bid to identify new medicines that can deliver nucleic acids. The deal, announced Monday

July 18, 2023

Pharmanovia announces acquisition of Sanofi’s CNS brands

The brands are intended for four CNS disorders: anxiolytic, psycholeptic, anti-epileptic and anti-psychotic. Credit: OlgaReukova/Shutterstock.com. UK-based Pharmanovia has announced the acquisition of 11 central nervous

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.